Description

AdvaCare is a CE, ISO and USFDA manufacturer of RT-PCR COVID-19 (Coronavirus) Nucleic Acid Test Kit.

AccuQuik™ RT-PCR SARS-CoV-2 Nucleic Acid Test Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2, novel coronavirus which was identified in 2019 at Wuhan City, and from there spread around the globe. Novel coronavirus (SARS-CoV-2) can be identified via multiplex PCR-fluorescent probe technology in upper and lower respiratory tract specimens (such as oropharyngeal swabs, nasopharyngeal swabs and sputum).

Thanks to its designed dual-target gene detection primer probe, our AccuQuik™ RT-PCR COVID-19 kit works with a high-efficiency RT-PCR reaction system for detection. After the end of the reaction, the results will be determined through analysis of the cycle threshold (Ct) of each channel. Moreover, the kit is designed with human housekeeping gene RNaseP for monitoring sampling, extraction, specimen addition, amplification and other related processes as an internal standard to effectively prevent false positive and false negative results, so as to ensure the specificity and accuracy of the test results.

Polymerase chain reaction (PCR) is a method used in molecular biology: by multiplying DNA samples PCR method amplifies in a more manageable size for study and analysis.

Reverse transcription polymerase chain reaction (RT-PCR) is a laboratory technique combining reverse transcription of RNA into DNA and amplification of specific DNA targets using PCR method. This allows to analyze gene expression and quantification of viral RNA in specimens.